PTR1 inhibitors based on aryl-2-nitroethyl triamino-pyrimidines as promising anti-Trypanosoma agents
Jan. 24, 2024
To combat trypanosomiasis and leishmaniasis, researchers from the University of Modena and Reggio Emilia and collaborators conducted a study focusing on pteridine reductase 1 (PTR1), a catalytic protein crucial to the folate metabolic pathway in Trypanosomatid parasites.